Header

UZH-Logo

Maintenance Infos

Publications for Tameris, M

Navigate back| Up a level
Export as
Group by:
Jump to:
Number of items: 3.

2018

Van Der Meeren, Olivier; Hatherill, Mark; Nduba, Videlis; Wilkinson, Robert J; Muyoyeta, Monde; Van Brakel, Elana; Ayles, Helen M; Henostroza, German; Thienemann, Friedrich; Scriba, Thomas J; Diacon, Andreas; Blatner, Gretta L; Demoitié, Marie-Ange; Tameris, Michele; Malahleha, Mookho; Innes, James C; Hellström, Elizabeth; Martinson, Neil; Singh, Tina; Akite, Elaine J; Khatoon Azam, Aisha; Bollaerts, Anne; Ginsberg, Ann M; Evans, Thomas G; Gillard, Paul; Tait, Dereck R (2018). Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. New England Journal of Medicine, 379(17):1621-1634.

2017

Chen, Ray Y; Via, Laura E; Dodd, Lori E; Walzl, Gerhard; Malherbe, Stephanus T; Loxton, André G; Dawson, Rodney; Wilkinson, Robert J; Thienemann, Friedrich; Tameris, Michele; Diacon, Andreas H; Liu, Xin; et al (2017). Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial. Gates Open Research:1:9.

2015

Kaufmann, S; Bloom, B; Brosch, R; Cardona, P-J; Dockrell, H; Fritzell, B; Grode, L; Hanekom, W; Hokey, D; Levin, M; Martin, C; Sander, P; Scriba, T; Shaligram, U; Tameris, M; von Reyn, F; Walker, B; Weiner, J; White, R G; Schrager, L (2015). Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Vaccine, 33(26):3047-3055.

This list was generated on Fri Apr 19 21:17:25 2019 CEST.